Institut Català de la Salut
[Midaglia L, Montalban X, Tintoré M] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Felipe-Rucián A] Servei de Neurologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Delgado Alvarez I] Servei de Radiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
Vall d'Hebron Barcelona Hospital Campus
2023-09-01T07:41:04Z
2023-09-01T07:41:04Z
2023-07-20
Acquired demyelinating syndrome; Multiple sclerosis; Myelin oligodendrocyte glycoprotein
Síndrome desmielinizante adquirido; Esclerosis múltiple; Glicoproteína de oligodendrocitos de mielina
Síndrome desmielinizant adquirida; Esclerosi múltiple; Glicoproteïna d'oligodendròcits de mielina
The clinical-radiological and biological overlap of the spectrum of pediatric demyelinating disorders makes the diagnostic process of a child with an acquired demyelinating syndrome truly challenging. We present a 9-year-old girl with subacute symptoms of severe decrease in bilateral visual acuity and gait ataxia. An urgent MRI showed inflammatory-demyelinating lesions affecting the periaqueductal gray matter, the cerebellar hemispheres, the area postrema as well as both optic nerves and chiasm. Likewise, multisegmental involvement of the cervical and dorsal spinal cord was found, with short and peripheral lesions. Anti myelin oligodendrocyte glycoprotein (MOG) antibodies (Abs) were positive in cerebrospinal fluid (CSF) and weakly in serum. Oligoclonal bands (OB) were positive in CSF. Based on all this, the diagnosis of MOG antibody disease (MOGAD) with a neuromyelitis optica spectrum disorder (NMOSD)-like picture was made. Given the good clinical and radiological recovery after the acute phase treatment, and that anti MOG Abs became negative, it was decided to keep the patient without specific treatment. However, during follow-up, while the patient was asymptomatic, a control brain MRI showed the appearance of new lesions with morphology and topography suggestive of multiple sclerosis (MS). This, added to the presence of OB, made the diagnosis of pediatric-onset MS (POMS) likely. Immunosuppressive treatment was restarted with a good response since then. Unlike adult-onset MS, children with POMS may usually not have entirely typical clinical and radiological features at presentation. In many cases, the time factor and close clinical and radiological monitoring could be critical to make an accurate diagnosis.
Artículo
Versión publicada
Inglés
Mielina - Malalties - Imatgeria; Glicoproteïnes; Infants; DISEASES::Nervous System Diseases::Demyelinating Diseases; Other subheadings::Other subheadings::Other subheadings::/diagnostic imaging; CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Glycoproteins::Membrane Glycoproteins::Butyrophilins::Myelin-Oligodendrocyte Glycoprotein; NAMED GROUPS::Persons::Age Groups::Child; ENFERMEDADES::enfermedades del sistema nervioso::enfermedades desmielinizantes; Otros calificadores::Otros calificadores::Otros calificadores::/diagnóstico por imagen; COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::glicoproteínas::glicoproteínas de membranas::butirofilinas::glicoproteína mielínica del oligodendrocito; DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::niño
Frontiers Media
Frontiers in Neuroscience;17
https://doi.org/10.3389/fnins.2023.1205065
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - CEMCAT [136]
Articles científics - HVH [3396]